Octagon Capital Advisors LP Monte Rosa Therapeutics, Inc. Transaction History

Octagon Capital Advisors LP

  • $414 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$4.53 - $8.4 $90,147 - $167,160
19,900 New
19,900 $136,000
Q1 2022

May 16, 2022
SELL
$10.36 - $20.41 $1.55 Million - $3.06 Million
-150,000 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$18.59 - $42.21 $1.64 Million - $3.72 Million
-88,045 Reduced 36.99%
150,000 $3.34 Million
Q2 2021

Aug 16, 2021
BUY
$18.86 - $22.7 $4.49 Million - $5.4 Million
238,045 New
238,045 $5.4 Million

Others Institutions Holding GLUE

# of Institutions
83
Shares Held
43.9M
Call Options Held
141K
Put Options Held
31.2K
View Full List

About Monte Rosa Therapeutics, Inc.

GLUE Quotes by TradingView
  • Ticker GLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,713,900
  • Market Cap $397M
  • Description
  • Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...
More about GLUE
Track This Portfolio

Track Octagon Capital Advisors LP Portfolio

Follow Octagon Capital Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Octagon Capital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Octagon Capital Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email